ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
Dow Jones
40,287.53
0.00%
US Dollar vs MXN
18.04374
-0.11%
Brent Oil
81.355
-1.12%
Bitcoin
67,605.78
-0.81%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
22/07/202407:30Business WireRegulatory Approval Obtained for Arch Insurance North America’s Acquisition of the U.S. MidCorp and Entertainment Businesses of AllianzNASDAQ:ACGLArch Capital Group Ltd
22/07/202407:30GlobeNewswire Inc.HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200NASDAQ:GMDAGamida Cell Ltd
22/07/202407:30GlobeNewswire Inc.Exela Technologies and AIDEO Technologies Enter Strategic AllianceNASDAQ:XELAExela Technologies Inc
22/07/202407:30Business WireAmbac to Release Second Quarter 2024 Results on August 5, 2024NYSE:AMBCAmbac Financial Group Inc
22/07/202407:30Business WireAmTrust Recognized as 2024 “Best and Brightest” Companies to Work For
22/07/202407:30GlobeNewswire Inc.Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast CancerNASDAQ:ATOSAtossa Therapeutics Inc
22/07/202407:30GlobeNewswire Inc.RSports Interactive Acquires GameBlazers, a Next Generation Daily Fantasy Sports Gaming Company and Collectible Trading Platform
22/07/202407:30GlobeNewswire Inc.OTORIO's Midyear Report Reveals Alarming Trends and Proactive Strategies in OT-IoT-CPS Security
22/07/202407:30Business WireDesktop Metal Announces Sale of First PureSinter™ Furnace to AmPd LabsNYSE:DMDesktop Metal Inc
22/07/202407:30GlobeNewswire Inc.HeartCore to Authorize Second Dividend PaymentNASDAQ:HTCRHeartCore Enterprises Inc
22/07/202407:30Business WireNUBURU Announces Revised Date for Strategic 1-for-40 Reverse Stock Split
22/07/202407:30GlobeNewswire Inc.Connexa Regains Full Nasdaq ComplianceNASDAQ:YYAIConnexa Sports Technologies Inc
22/07/202407:30Business WireGlobal Partners LP to Host Second-Quarter 2024 Financial Results Conference Call on August 7, 2024NYSE:GLPGlobal Partners LP
22/07/202407:30GlobeNewswire Inc.Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct OfferingNASDAQ:RANIRani Therapeutics Holdings Inc
22/07/202407:30Business WireMEI Pharma to Consider Strategic AlternativesNASDAQ:MEIPMEI Pharma Inc
22/07/202407:30GlobeNewswire Inc.Open Lending to Announce Second Quarter 2024 Results on August 8, 2024NASDAQ:LPROOpen Lending Corporation
22/07/202407:30GlobeNewswire Inc.Vericel Announces Appointment of Karen Mahoney as Chief Human Resources OfficerNASDAQ:VCELVericel Corporation
22/07/202407:30Business WireMotorcar Parts of America Expands Its Rotating Electrical, Brake-Related and Wheel Hub Product CoverageNASDAQ:MPAAMotorcar Parts and Associates Inc
22/07/202407:30GlobeNewswire Inc.NANO Nuclear Energy Appoints Distinguished Nuclear Regulatory Expert David Tiktinsky as Head of Nuclear Regulatory Licensing after nearly 40-years with the Nuclear Regulatory Commission (NRC)NASDAQ:NNENano Nuclear Energy Inc
22/07/202407:30GlobeNewswire Inc.CSW Industrials Announces Date for Fiscal First Quarter 2025 Earnings Release Conference CallNASDAQ:CSWICSW Industrials Inc
22/07/202407:29GlobeNewswire Inc.Willis Lease Finance Corporation Hires SR Technics Veteran, Caroline M. Vandedrinck, to Run its Growing Services BusinessesNASDAQ:WLFCWillis Lease Finance Corporation
22/07/202407:28Edgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
22/07/202407:28PR Newswire (Canada)Corporation de Sécurité Garda World annonce une offre de billets de premier rang d'un montant principal global de 400 millions $ US échéant en 2032
22/07/202407:28PR Newswire (Canada)Garda World Security Corporation Announces Offering of US$400 Million of Senior Notes due 2032
22/07/202407:25Business WireTextron Aviation, al Farnborough International Airshow 2024, mostra i velivoli da addestramento multimotore per equipaggi militari di prossima generazioneNYSE:TXTTextron Inc
22/07/202407:23PR Newswire (Canada)goeasy Ltd. Announces Proposed Offering of US$150 Million of Senior Unsecured NotesTSX:GSYGoeasy Ltd
22/07/202407:22Crypto BriefingCrypto funds see $3.2 billion inflows in July amid bullish investor sentimentCOIN:FLOWUSDFlow
22/07/202407:22PR Newswire (Canada)goeasy Ltd. Announces Preliminary Second Quarter Selected DataTSX:GSYGoeasy Ltd
22/07/202407:20PR Newswire (US)EMPRESA NACIONAL DEL PETRÓLEO LAUNCHES ANY AND ALL CASH TENDER OFFER AND MAXIMUM TENDER OFFER FOR U.S. DOLLAR NOTES DUE 2026 AND 2031
22/07/202407:20PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - JRVTSXV:JRVJervois Global Limited

Su Consulta Reciente

USOTC
BNPQY
BNP Paribas (QX)
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
USOTC
BASFY
BASF (QX)
FX
USDMXN
US Dollar vs MXN
NYSE
CVX
Chevron
NYSE
DIS
Walt Disney
AMEX
XLV
Health Care Select Sector
USI
USTECH100
US Tech 100
NASDAQ
AMZN
Amazon.com
AMEX
SPY
SPDR S&P 500
CCOM
US30
US 30
NASDAQ
TSLA
Tesla
NYSE
AXP
American Express
PM
XAUUSD
Gold vs US Dollar
FX
EURUSD
Euro vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados